Latest ALS Stories
New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS). The study, published by Wiley in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, found that diets high in lycopene, beta-cryptoxanthin, and vitamin C did not reduce ALS risk. Carotenoids give fruits and vegetables their bright orange, red,...
redOrbit Staff & Wire Reports - Your Universe Online A pair of Harvard University stem cell biologists have reportedly demonstrated a technique with which they can transform one type of already differentiated neuron into another. The discovery, reported by the Cambridge, Massachusetts-based Ivy League school in a statement released Sunday, demonstrates it is possible that the human brain “is not as immutable as we always thought, because at least during an early window of time one...
SAN DIEGO, Jan. 14, 2013 /PRNewswire-USNewswire/ -- Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The results of the study will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. "There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," said study author...
Sentrana researchers presented Prize4Life ALS Prediction Challenge research that will help accelerate the discovery of treatments and a cure for ALS . Washington, DC (PRWEB) January 11, 2013 Dr. Liuxia Wang and modeler Guang “Eric” Li of Sentrana’s quantitative modeling research department presented their prize winning research at the international Research in Computational Molecular Biology (RECOMB) conference. The DREAM – Phil Bowen ALS Prediction Prize Challenge was created by...
Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The results of the study were released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. "There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," said study author Stefania Corti, MD, PhD, with the...
CNS-targeted Liposomal Drug Delivery System Enhances Institute's Formulation Abilities CAMBRIDGE, Mass. and LEIDEN, Netherlands, Jan. 8, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a new collaboration with to-BBB to investigate potential treatments for ALS (aka Motor Neuron or Lou Gehrig's disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO) "This partnership brings a new potential...
ROCKVILLE, Md., Jan. 4, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the fifth annual Biotech Showcase in San Francisco on Tuesday, January 8, 3:45 p.m. PT, in Room Powell. Garr will present a business overview, including a first look at the Phase I/II Stroke/NSI-566 cell therapy trial expected to commence in Beijing within several weeks. Garr will also provide an update on the company's ALS cell therapy trial...
AMES, Iowa, Dec. 19, 2012 /PRNewswire/ -- The Special Committee of the Board of Directors of Sauer-Danfoss Inc. ("Sauer-Danfoss") (NYSE: SHS) announced today that it has retained Lazard as the Special Committee's independent financial advisor and Kirkland & Ellis LLP as its independent legal counsel. As Sauer-Danfoss previously announced, on November 28, 2012 the Board of Directors formed a Special Committee of independent directors to consider, among other things, the proposal...
WASHINGTON, Dec. 10, 2012 /PRNewswire-USNewswire/ -- Researchers supported by The ALS Association have discovered an important process that puts neurons at risk of the cell death, which characterizes numerous neurodegenerative diseases. The discovery, which was published today in the Proceedings of the National Academy of Sciences, highlights the links between several proteins known to go awry in ALS and a related disease, frontotemporal dementia (FTD). ALS is a progressive...
ROCKVILLE, Md., Dec. 10, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the International Symposium on ALS/MND in Chicago, sponsored by the Motor Neurone Disease Association. In a Thursday presentation, "RESULTS OF PHASE 1 TRIAL OF SPINAL CORD...
